A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Incidental BE was common and associated with high-risk features that were similar to or more severe than those found in BE diagnosed by traditional methods.

HealthDay News — The viability of hospital-based emergency care in the United States is at risk, according to a RAND report released April 7.